We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

87 hedge funds and large institutions have $107M invested in Antares Pharma, Inc. in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

40% more capital invested

Capital invested by funds: $76.7M → $107M (+$30.7M)

6% more funds holding

Funds holding: 82 → 87 (+5)

39% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 33

97% less call options, than puts

Call options by funds: $9K | Put options by funds: $291K

Holders
87
Holders Change
+5
Holders Change %
+6.1%
% of All Funds
2.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
20
Reduced
33
Closed
9
Calls
$9K
Puts
$291K
Net Calls
-$282K
Net Calls Change
+$58K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$2.25M
2
BFA
BlackRock Fund Advisors
California
+$965K
3
DM
Deerfield Management
New York
+$631K
4
B
Baird
Wisconsin
+$566K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$399K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$6.74M
2
GTC
Ghost Tree Capital
New York
-$2.01M
3
Citadel Advisors
Citadel Advisors
Florida
-$555K
4
WHI
William Harris Investors
Illinois
-$444K
5
BIT
BlackRock Institutional Trust
California
-$224K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$20.8M +$631K +280,700 +4%
BC
2
Broadfin Capital
New York
$12.1M +$2.25M +1,000,000 +27%
BIT
3
BlackRock Institutional Trust
California
$10.2M -$224K -99,749 -2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$10.2M +$399K +177,715 +5%
BFA
5
BlackRock Fund Advisors
California
$8.34M +$965K +429,797 +15%
AC
6
Armistice Capital
New York
$6.68M +$5.84M +2,600,000 New
WHI
7
William Harris Investors
Illinois
$5.36M -$444K -197,590 -9%
State Street
8
State Street
Massachusetts
$4.9M +$52.2K +23,244 +1%
Northern Trust
9
Northern Trust
Illinois
$3.26M -$120K -53,622 -4%
KCM
10
Kingdon Capital Management
New York
$3M – – –
PI
11
Putnam Investments
Massachusetts
$1.86M -$15K -6,695 -0.9%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$1.71M -$1.55K -690 -0.1%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.69M +$18.1K +8,047 +1%
Millennium Management
14
Millennium Management
New York
$1.13M -$6.74M -3,000,655 -87%
TCIM
15
TIAA CREF Investment Management
New York
$1.05M -$51K -22,695 -5%
BIM
16
BlackRock Investment Management
Delaware
$873K -$9.19K -4,089 -1%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$851K – – –
AC
18
Avenir Corporation
Virginia
$806K -$56.2K -25,000 -7%
Charles Schwab
19
Charles Schwab
California
$777K +$94.7K +42,171 +16%
MIG
20
Mariner Investment Group
New York
$723K – – –
CIBC Private Wealth Group
21
CIBC Private Wealth Group
Georgia
$707K -$4.49K -2,000 -0.7%
B
22
Baird
Wisconsin
$648K +$566K +252,000 New
ACP
23
Acuta Capital Partners
California
$598K +$523K +232,762 New
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$556K +$2.07K +921 +0.4%
AllianceBernstein
25
AllianceBernstein
Tennessee
$507K -$23.8K -10,600 -5%
1
2 3 4

ATRS Hedge Fund Activity: Q4 2014 in Review

87 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q4 2014, worth a combined $107M — up 40% from $76.7M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ATRS positions and 9 closed out — a net gain of 7 holders — while 20 added to existing stakes and 33 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $2.25M. The largest seller was Millennium Management, cutting an estimated $6.74M.

  • 87 institutional investors held Antares Pharma, Inc. (ATRS) as of Q4 2014, up from 82 in Q3 2014.
  • Funds reported $107M of Antares Pharma, Inc. stock for Q4 2014, up 40% quarter-over-quarter.
  • 16 funds opened new Antares Pharma, Inc. positions in Q4 2014 and 9 closed out, a net change of +7 holders.
  • The largest Antares Pharma, Inc. buyer in Q4 2014 was Broadfin Capital, an estimated $2.25M added.
  • The largest Antares Pharma, Inc. seller in Q4 2014 was Millennium Management, an estimated $6.74M sold.

Based on aggregated 13F filings for Q4 2014.